Paclitaxel (P) and cisplatin (C) concurrent with radiotherapy (RT) for larynx preservation (LP) in advanced resectable laryngeal (L) and hypopharyngeal (HP) squamous cell carcinoma (SCC): Final results of a prospective multicenter phase II trial

被引：0

作者：

Bueno, Thiago de Oliveira ^{[1
]}

Carvalho, Andre Lopes ^{[4
]}

Assis Pellizzon, Antonio Cassio ^{[3
]}

Pereira, Augusto ^{[1
]}

dos Santos, Carlos Roberto ^{[4
]}

Kowalski, Luiz Paulo ^{[2
]}

Viana, Luciano ^{[5
]}

Duarte, Marcos ^{[6
]}

Pierre, Renato ^{[7
]}

de Santana, Rosane Oliveira ^{[8
]}

Lincoln, Ricardo ^{[9
]}

Nicolau, Ulisses Ribaldo ^{[1
]}

Feher, Olavo ^{[10
]}

机构：

[1] Hosp AC Camargo Fund Antonio Prudente, Dept Med Oncol, Sao Paulo, Brazil

[2] Hosp AC Camargo Fund Antonio Prudente, Dept Head & Neck Surg, Sao Paulo, Brazil

[3] Hosp AC Camargo Fund Antonio Prudente, Dept Radiotherapy, Sao Paulo, Brazil

[4] Hosp Canc Barretos, Fundacao Pio 12, Dept Head & Neck Surg, Barretos, Brazil

[5] Hosp Canc Barretos, Fundacao Pio 12, Dept Med Oncol, Barretos, Brazil

[6] Hosp Canc Barretos, Fundacao Pio 12, Dept Radiotherapy, Barretos, Brazil

[7] Inst Canc Ceara, Dept Radiotherapy, Fortaleza, Ceara, Brazil

[8] Inst Canc Ceara, Dept Med Oncol, Fortaleza, Ceara, Brazil

[9] Inst Canc Ceara, Dept Head & Neck Surg, Fortaleza, Ceara, Brazil

[10] ICESP, Dept Med Oncol, Sao Paulo, Brazil

来源：

ORAL ONCOLOGY | 2013年 / 49卷

关键词：

D O I：

10.1016/j.oraloncology.2013.03.052

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OP044

引用

页码：S22 / S22

页数：1

共 50 条

[1] Paclitaxel (P) and cisplatin (C) concurrent with radiotherapy (RT) for larynx preservation (LP) in advanced resectable laryngeal (L) and hypopharyngeal (HP) squamous cell carcinoma (SCC): Final results of a prospective phase II trial
Nicolau, Ulisses Ribaldo
Oliveira, Thiago Bueno
Carvalho, Andre Lopes
Santana, Rosane O.
Valadares, Adriana D.
Salvajoli, Joao Victor
Chinen, Ludmilla T. D.
Araujo, Bertha Catherine B.
Martins, Sandro Jose
Castro Junior, Dalvaro Oliveira
Kowalski, Luiz Paulo
Feher, Olavo
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[2] Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II
Dietz, A.
Wichmann, G.
Kuhnt, T.
Pfreundner, L.
Hagen, R.
Scheich, M.
Koelbl, O.
Hautmann, M. G.
Strutz, J.
Schreiber, F.
Bockmuehl, U.
Schilling, V.
Feyer, P.
de Wit, M.
Maschmeyer, G.
Jungehuelsing, M.
Schroeder, U.
Wollenberg, B.
Sittel, C.
Muenter, M.
Lenarz, T.
Klussmann, J. P.
Guntinas-Lichius, O.
Rudack, C.
Eich, H. T.
Foerg, T.
Preyer, S.
Westhofen, M.
Welkoborsky, H. J.
Esser, D.
Thurnher, D.
Remmert, S.
Sudhoff, H.
Goerner, M.
Buenzel, J.
Budach, V.
Held, S.
Knoedler, M.
Lordick, F.
Wiegand, S.
Vogel, K.
Boehm, A.
Flentje, M.
Keilholz, U.
ANNALS OF ONCOLOGY, 2018, 29 (10) : 2105 - 2114
[3] Assessment of Rate of Laryngeal Preservation in Patients undergoing Radiotherapy with Concurrent Chemotherapy for Advanced Squamous Cell Carcinoma of Larynx: A Prospective Interventional Study
Saseendran, Devika
Khader, Shehna Abdul
Raghavan, Ajithkumar Vilasini
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (11) : XC1 - XC4
[4] PD-1 Inhibitors combined with paclitaxel (Albumin-bound) and cisplatin for larynx preservation in locally advanced laryngeal and hypopharyngeal squamous cell carcinoma: a retrospective study
Fang, Qi
Xu, Pengfei
Cao, Fei
Wu, Di
Liu, Xuekui
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (12) : 4161 - 4168
[5] PD-1 Inhibitors combined with paclitaxel (Albumin-bound) and cisplatin for larynx preservation in locally advanced laryngeal and hypopharyngeal squamous cell carcinoma: a retrospective study
Qi Fang
Pengfei Xu
Fei Cao
Di Wu
Xuekui Liu
Cancer Immunology, Immunotherapy, 2023, 72 : 4161 - 4168
[6] Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix
Fields, AL
Anderson, PS
Goldberg, GL
Wadler, S
Beitler, J
Sood, B
Runowicz, CD
GYNECOLOGIC ONCOLOGY, 1996, 61 (03) : 416 - 422
[7] Paclitaxel, cisplatin, 5-fluorouracit and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck. A phase II trial
Merlano, M
Russi, EG
Numico, G
Colantonio, I
Garrone, O
Pelissero, A
Granetto, C
Gasco, M
Di Costanzo, G
Heouaine, A
Taglianti, RV
Cipolat, M
RADIOTHERAPY AND ONCOLOGY, 2005, 75 (02) : 193 - 196
[8] Phase II trial of concurrent split course hyperfractionated radiotherapy (Hfx RT), cisplatin (DDP) and paclitaxel (P) in patients with recurrent, previously irradiated squamous cell carcinoma of the head and neck (SCCHN). Results of RTOG 9911.
Langer, CJ
Harris, J
Horwitz, E
Nicolaou, N
Kies, M
Curran, W
Wong, S
Ang, KK
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 490S - 490S
[9] Erlotinib (E) combined with cisplatin (C) and radiotherapy (RT) for patients with locally advanced squamous cell cervical cancer: A phase II trial
Ferreira, C. G.
Erlich, F.
Carmo, C. C.
Viegas, C.
Cidade, I. J.
Camisao, C. C.
Small, I. A.
Fontao, K.
Martins, R. G.
Rodrigues, A. N.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[10] Final results of the randomized phase II DeLOS- II trial: Induction chemotherapy (IC) followed by radiotherapy (R) vs. cetuximab (E) plus IC and R for functional larynx preservation in resectable laryngeal and hypopharyngeal cancer (LHSCC).
Dietz, Andreas
Wichmann, Gunnar
Flentje, Michael
Hagen, Rudolf
Koelbl, Oliver
Schreiber, Frank
Schilling, Volker
Maschmeyer, Georg
Schroeder, Ursula
Sittel, Christian
Lenarz, Thomas
Klussmann, Jens Peter
Guntinas-Lichius, Orlando
Rudack, Claudia
Foerg, Thomas
Westhofen, Martin
Welkoborsky, HansJuergen
Esser, Dirk
Held, Swantje
Keilholz, Ulrich
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)

← 1 2 3 4 5 →